About Concentrics Research
Concentrics Research is a Healthcare company based in Indianapolis (United States) founded in 1999, and was acquired by Bindley Capital Partners in December 2002. Late-stage (Phase II-IV trials) CRO. The company has 47 employees. Concentrics Research offers products and services including Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Late Stage. Its legal entity is CONCENTRICS RESEARCH, LLC. Its competitors include United BioSource Corporation, Launch Therapeutics and Nexus Biosciences; 1 of its 3 listed competitors has raised funding.
Company details
Concentrics Research is a CRO with capabilities to conduct Rx-to-OTC Switch and Late-Stage (Phase II-IV) for the pharmaceutical, biotechnology, medical device, nutritional, and consumer healthcare product industries. The companys CRO service portfolio includes Protocol development, Project Management, Site Management, Investigator Meeting Planning and Conduct, Start-upKick-off Meetings, Clinical Monitoring, Data Collection (various EDC methods as well as paper), Data Management, Statistical analysis and Medical Writing. They offer their clinical development services for drugs, medical devices and dietary supplements. Concentrics Research has 3 major divisions - CRO, Site Management Organization (Concentrics Center for Research), and Concentrics Strategy Center (Initiates and Facilitates study conduct). The research site has capabilities to conduct Qualitative pre-testing for Rx-to-OTC Switch studies, Clinical research studies and Specialized custom marketing research.
- Headquarters Indianapolis, United States
- Employees 47
- Stage Acquired
- SectorsHealthcare
- Website concentricsresearch.com
- Acquired by Bindley Capital Partners (Dec 2002)
- Legal Name Concentrics Research, Llc
- Investors
- Employee Count47
- Acquired byBindley Capital Partners
(Dec 2002)
Products & Services of Concentrics Research
Concentrics Research offers a comprehensive portfolio of products and services, including Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research.
Service for transitioning prescription drugs to over-the-counter status.
Late-stage trials for drugs and devices in healthcare.
Regulated research for healthcare marketing strategies.
Investors in Concentrics Research
Concentrics Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bindley Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bindley Capital Partners is engaged in private investment management. | bindley.com | Indianapolis, United States |
Investor details for Concentrics Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Concentrics Research
8 people are tracked at Concentrics Research (3 in leadership, 5 in team); the tracked headcount is 47.
| Name | Role | Group |
|---|---|---|
Julie Aker | President & Chief Executive Officer | Leadership |
Sara Travis (Stuteville) | Vice President, Operations | Leadership |
Melissa Beck | Director Project Operations | Leadership |
Jamie Sanders | Associate Project Manager | Team |
Caroline Clark | Project Manager | Team |
Kimberly Neidigh | Clinical Research Associate | Team |
Nina Garrett | Clinical Operations Project Manager, II | Team |
Kate Martin | Clinical Research Associate On Assignment With Execupharm | Team |
Complete people profiles for Concentrics Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Concentrics Research
2 dated milestones of Concentrics Research across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Concentrics Research is founded.
- Exit Acquired by Bindley Capital Partners.
Competitors of Concentrics Research
Concentrics Research has 3 listed competitors in our database, 1 of them funded. They include United BioSource Corporation, Launch Therapeutics and Nexus Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ubc.com | 2003 | Blue Bell, United States | $278M | Pharmaceutical support services | ||
| launchtx.com | 2022 | Boston, United States | Late-stage clinical development services are provided for biopharma companies. | |||
| nexusbiosciences.com | 2012 | Carlsbad, United States | CRO specializing in late stage, observational and post-approval studies |
Detailed competitors of Concentrics Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Concentrics Research
The website of Concentrics Research (concentricsresearch.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 302.9% vs previous month
Websites whose visitors overlap most with Concentrics Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
qualmedicaresearch.com | qualmedicaresearch.com | 100% | β | ||
indianaclinicalresearch.com | indianaclinicalresearch.com | 99% | β | ||
nccindiana.com | nccindiana.com | 94% | #2,780,993 | β | |
| urologyin.com | 87% | 14.6K | #1,272,061 | View details | |
| indianactsi.org | 82% | 16.1K | #1,710,309 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for Concentrics Research
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Concentrics Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Concentrics Research
Complete news archive for Concentrics Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concentrics Research
Concentrics Research was founded in 1999.
Concentrics Research is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Concentrics Research has 47 employees.
Concentrics Research is a CRO with capabilities to conduct Rx-to-OTC Switch and Late-Stage (Phase II-IV) for the pharmaceutical, biotechnology, medical device, nutritional, and consumer healthcare product industries. The companys CRO service portfolio includes Protocol development, Project Management, Site Management, Investigator Meeting Planning and Conduct, Start-upKick-off Meetings, Clinical Monitoring, Data Collection (various EDC methods as well as paper), Data Management, Statistical analysis and Medical Writing. They offer their clinical development services for drugs, medical devices and dietary supplements. Concentrics Research has 3 major divisions - CRO, Site Management Organization (Concentrics Center for Research), and Concentrics Strategy Center (Initiates and Facilitates study conduct). The research site has capabilities to conduct Qualitative pre-testing for Rx-to-OTC Switch studies, Clinical research studies and Specialized custom marketing research.
Concentrics Research's top competitors include United BioSource Corporation, Nexus Biosciences and Launch Therapeutics.
Concentrics Research offers Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research.
Concentrics Research has 1 investor. Key investors include Bindley Capital Partners.
Concentrics Research operates through Concentrics Research, Llc.
Yes. Concentrics Research was acquired by Bindley Capital Partners in December 2002.

